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Genes located at the Fu-1, Fu-2, and H-2 chromosomal regions are the major
polymorphic systems in the mousewhich govern the pathological consequences of
inoculation with Friend virus (FV) (reference 1 and footnote 1). Fu-1 and Fu-2
appear to govern susceptibility to the helper virus component and to the
defective SFFV1 component, respectively, of the FV complex, both of which
are necessary for induction of the characteristic erythroleukemic disease. The
H-2-associated gene, on the other hand, appears to exert its influence relatively
late during the development of the disease syndrome, since its effects are
demonstrable only aftercellularinfection and virus proliferation have occurred.
Because early experiments showed that the H-2d haplotype of BALB/c mice
favored the occurrence of the FV disease whereas the H-2b haplotype of C57BL
mice was associated with relative resistance to the disease (2), the congenic
BALB/c-H-2° (BALB.B) strain was bred in our laboratories. Comparisons of
BALB/c and BALB.B mice showed thatthey are equally susceptible to FV bythe
criterion of spleen focus induction, which is a measure of cellular infectivity, but
by the criterion of splenomegaly induction BALB.B mice require about 10-20
times as much FV to produce the same pathological response as that ofBALB/c
mice (3).
In order to advance our studies of the mechanism of the H-2 effect on the FV
disease, we have embarked on a series of experiments designed to examine the
properties of tumor cells induced with FV in BALB/c and in congenic BALB.B
mice subsequently grown in culture. We now report some similarities and
differences between two such cell lines. Although the differences we have
observed cannot yet be attributed with certainty to the differences in H-2
genotype, they have provided uswith a new frame of reference for further studies
of this problem.
* Supported by contract NOl CP NCI 33249 from the National Cancer Institute.
t Fellow of the Leukemia Society of America, Inc.
'Abbreviations used in this paper: BALB.B, BALB/c-H-2° congenic partner to BALB/c (H-2");
FV, Friend virus complex; HFL/b-sc, solid subcutaneous tumor derived from FV-infected BALB.B
spleen fragments; HFL/b-tc, HFL/b-sc grown in tissue culture; HFL/d-as, HFL/d-tc grown in ascitic
form in vivo; HFL/d-sc, solid subcutaneous tumor derived from FV-infected BALB/c spleen frag-
ments ; HFL/d-tc, HFL/d-sc grown in tissue culture; LLV-F, lymphatic leukemia isolated from FV;
MEM-Earle's, MEM (Eagle's) with Earle's salts; MoILV, Moloney leukemia virus; PBS, phosphate-
buffered saline; PFU, plaque-forjning units; SFFU, spleen focus-forming units; SFFV, defective
component of FV which in the presence of helper viruses induces spleen foci in susceptiblehosts.
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Materials and Methods
Mice.
￿
With the exception of some oftheanimals used for virus titrations, all mice were from our
own colony of highly inbred mouse strains. The congenic mouse strain referred to as BALB.B, was
established from the (BALB/c x C57BL/10)F, cross. This strain was inbred after 13 consecutive
backcrosses to theBALB/c parental strain with selection in each generation forthe H-2° haplotypeof
the C57BL/10 ancestor. Thus, any differences observed between BALB/c and BALB.B mice can be
attributed with high probability to a gene or genes in the immediate vicinity of the H-2 region of
linkage group IX (chromosome 17).
For virus titrations, DBA/2Ha, random-bred Ha/ICR Swissand BALB/c mice were obtained from
the West Seneca Laboratories, Buffalo, N. Y. Animalswere usually 6- to 10-wk old at thetime ofvirus
inoculation.
Viruses.
￿
The variant N-.NB-tropic strain of FV was used throughout these experiments. This
virus strain %as derived from the original N-tropic FV by forced passage in BALB/c mice (4).
N-NB-tropic FV is equally infective in DBA/2 (Fv-1") and BALB/c (Fv-1") mice and their F,
hybrids. Preparations of FV were obtained from thegreatly enlarged spleens of BALB/c mice infected
2 wk previously with N-.NB-tropic FV from asyngeneic donor. Thespleens were homogenized in nine
times their weight of cold phosphate-buffered saline (PBS). After slow centrifugation at 4°C to
remove large particulate matter from the homogenate, the supernate was recentrifuged for 4 min at
7,000g. The resulting supernate was stored in small ampules at -70°C and served as the basicvirus
preparation. When assayed in BALB/c mice, such preparations usually show a titer of about 5 x 10'
spleen focus-forming units (SFFU)/ml.
A lymphatic leukemia virus was isolated from N-tropic FV (LLV-F) by passage into newborn
C57BL (Fv-l') mice followed by blindpassagein weanling Ha/ICR swiss mice (5). Conversion to NB
tropism occurred during five subsequent serial passages in BALB/c mice. All LLV-Fstocks were free
of detectable spleen focus-forming activity. Moloney leukemia virus (MoILV) was obtained in 1964
from Dr. J. B. Moloney, National Cancer Institute, Bethesda, Md. This virus was considered NB
tropic after four passages in BALB/c mice. Stocks of LLV-F and Mo1LV were prepared as 20%
perfusates of leukemic BALB/c spleens. Enlarged spleens were pooled and perfused with McCoy's
medium containing 3% fetal calf serum, and thefluids were clarified at 2,400 gfor 10 min andstored
at -196°C. Stocks of LLV-F and of Mo1LV were titrated for their helper activity for SFFV by the
method of Steeves et al. (6) and showed 8 x 10' and 9 x 109 helper U/ml, respectively.
Virus Assays.
￿
FV was routinely titrated in vivo by the spleen focus assay (7). Diluted samples
were injected into the lateraltail veins of mice in 0.5-ml vol. 9 days laterthe spleens of therecipients
were excised, fixed in Bouin's solution, and examined for discrete, macroscopic, focal lesions on the
splenic surfaces. Virus titers were expressed in SFFU per milliliter.
Titrations in vitro of virus samples were performed by the XC plaque assay (8). For this assay,
embryo fibroblasts of the NIH Swiss (Fv-1") and BALB/c (Fv-1°) strains were obtained from
Microbiological Associates, Inc., Bethesda, Md. In addition embryo fibroblasts of the BALB/c and
DBA/2 (Fv-1") strains were obtained from animals in ourown colony. Virus titers were expressed in
plaque-forming units (PFU) permilliliter.
Tissue Culture. All cell lines grown in culture were established from their respective subcu-
taneous solid tumors. These lines consisted of nonadherent cells maintained in stationary suspen-
sion culture. Adherent cells were discarded. Essentially, tissue fragments from the various tumors
were minced in Eagle's minimum essential medium (MEM) with Earle's base plus glutamine
(MEM-Earle's), filtered through sterile gauze, and the resulting cell suspension washed five to six
times in MEM-Earle's. These cells were resuspended at a concentration of 5 x 108 cells/ml in
complete growth medium: MEM-Earle's containing 20% fetal calf serum, extra L-glutamine (0.58
mg/ml total), 100U/ml penicillin, and 100mcg/ml streptomycin . T-30flasks were seeded with 5 ml of
the cell suspensions and incubated at 37°C. After 24 h each culture was diluted fivefold with
complete growth medium and the cells redistributed in 5-ml vol into new T-30 flasks. Thecellswere
then maintained at a concentration of 5 x 108 celWml by periodic dilution with fresh growth
medium. Within 3 wk thecells in successful cultures appeared to be well adapted to growth in vitro.
Thereafter, the cells were maintained in complete growth medium containing 10% fetal calf serum
and0.292 mg/ml L-glutamine by planting 5-ml vol containing 5 x 10'cells/ml in T-30 flasks followed
by subculturing when the cell concentration reached 5 x 10° cells/ml (approximately 5 days). This
same growth medium was used for all cocultivation experiments as well.214
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Results
Derivation of BALB/c Tumor: HFL/d. 25-28 days after infection of a
BALB/c female mouse with N,NB-tropic FV, washed fragments of the greatly
enlarged spleen were transplanted subcutaneously to syngeneic hosts. Such
implants usually enlarged slowly but progressively. In the early transplant
generations, the recipients showed a concomitant primary FV-disease syndrome
as well as growth of the transferred tumor cells. For this reason it was important
to transfer the tumor at 7- to 14-day intervals, even though the tumors were
relatively small at this time . In later transplant generations, the transfer of
infectious virus with the tumor cells appeared much diminished, since the
accompanying primary disease syndrome seemed weaker or occasionally nonex-
istent. In addition, the growth of the transplanted tumors appeared to become
more rapid in later generations. Grossly, this tumor resembled those produced
originally by Buffett and Furth (9) and by Friend and Haddad (10) by similar
methods. This tumor has been designated HFL/d-sc; "d" refers to the H-2d type
of the mice from which this tumor was derived, and "sc" refers to subcutaneous
passage.
Derivation of BALB.B Tumor: HFL/b. The transplantable subcutaneous
tumor, HFL/b-sc, was induced in a congenic BALB .B female mouse. This tumor
was established in essentially the same manner as the H-2-congenic HFL/d-sc
tumor. However, it is notable that transfers of BALB.B-infected spleen frag-
ments showed only transient growth followed by tumor rejection in normal
syngeneic hosts, so that the tumor line could not be established in these hosts.
When the recipients were rendered anemic by bleeding (-0.3 ml three times a
week), beginning the day of transplantation, the transplants showed much more
reliable progressive growth (Table 1) . Grossly, progressively growing HFL/d-sc
and HFL/b-sc tumors were indistinguishable.
Characteristics of FV-Induced Tumor Cells In Vitro.
￿
Tissue cultures were
initiated from HFL/d-sc tumors on two separate occasions, separated by a 5-mo
interval, giving rise to cell lines, HFL/d-tc and HFL/d-tc-11. These cell lines have
shown indistinguishable properties by all criteria applied to theirstudy, and they
will not be discussed separately . The HFL/d-tc cells have been maintained in
continuous culture for 2.5 yr at present, and their properties have been stable
TABLE I
Effect ofBleeding on the Growth of HFL/b-sc Solid Implants in BALB.B Mice
* Number of mice with palpable tumors (minimum diameters, 5 mm)/number ofmice inoculated.
$Number of mice with no palpable tumors/number of mice originally showing palpable tumors
(minimum diameter, 5 mm).
Passage no .
Normal
Tumorgrowth Tumor
regression
Bled
Tumorgrowth
Tumor
regression
6 5/5* 5/5$ 4/4* 0/4$
8 6/6 4/6 4/4 0/4
13 10/10 4/10 4/4 0/4HERBERT A. FREEDMAN AND FRANK LILLY
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since about the 3rd mo in culture. The cells grow in suspension with or without
agitation, and neither extensive clumping nor flattenedfibroblastic or epithelioid
elements have been observed. Actively growing cells are spherical, range in size
from 10-20 gm, and havea doubling time ofapproximately 14 h.
Subcutaneous injection ofas few as 1 x 103 HFL/d-tc cells produced tumors in
syngeneic hosts within a maximum of 3 wk (Table II). Grossly, these tumors were
indistinguishable from the original HFL/d-sc tumor. Intraperitoneal inoculation
of 10"-106 cells resulted in cellular proliferation in the ascitic form in 20-60% of
the inoculated syngeneic hosts, which then died within 2-3 wk.
Tissue cultures initiated from the HFL/b-sc tumor have been maintained in
serial passage for approximately 2 yr. The resultant cell line, HFL/b-tc appeared
identical to the HFL/d-tc cell lines. However, implants of as many as 10'
TABLE II
Growth of Palpable Tumors in BALE/c Mice Receiving HFL/d-tc Cells Subcutaneously
* Number of mice with palpable tumors (minimum diameter, 5 mm)/number of mice inoculated.
HFL/b-tc cells rarely induced progressively growing tumors in normal syngeneic
hosts. Rather, it was necessary to render the mice anemic by bleeding in order to
achieve tumor growth in vivo, as noted previously with regard to the HFL/b-sc
tumor line. A detailed study of the growth properties in vivo of HFL/d-tc and
HFL/b-tc cells will be the subject of a subsequent paper.
Wright-stained preparations (11) of HFL/d-tc and HFL/b-tc cells revealed at
least three cell types. The most abundant cell appeared to be a proerythroblast
exhibiting a high nucleocytoplasmic ratio, deep blue-staining cytoplasm, nuclear
hyperchromatism, and coarse chromatin aggregates. Although most cells con-
tained a single round nucleus, occasional binucleate forms were present.
The second cell type appeared somewhat larger than the proerythroblast with
paler staining nucleus and cytoplasm. Nuclearchromatin was arranged in a fine,
open meshwork containing two to four large irregularly shaped nucleoli. Such
cells resemble very closelythose described by Friend et al. (11) and referred to as
primitive reticulum or "stem" cells. Mitoses were frequently observed among
both proerythroblasts and reticulum cells.
Erythroblasts in more advanced stages of maturity were present as well,
although reticulocytes or fully mature anucleate erythrocytes were absent.
Accordingly, the most advanced stage observed appeared identical to the
basophilic erythroblasts describedbyFriend et al. (11) and Ikawa et al. (12). This
Passage no.
No. of cells inoculated
107 106 106 104 10, 10' 10,
9 4/4*
13 9/9
15 5/5
18 8/8
21 7/7
56 6/6 4/4 3/5 2/5 0/5 0/5216
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third cell type appeared smaller than the proerythroblast and displayed a
strongly basophilic cytoplasm. Nuclei appeared condensed with coarse chroma-
tin clumping and marked decrease in nucleocytoplasmic ratio. The proportion of
stem cells to proerythroblasts and erythroblasts appeared to vary appreciably
with the density of the cell population, as well as from passage to passage.
Friend Virus Production by HFL/d Cells.
￿
Supernates of 10% saline homoge-
nates of HFL/d-sc tumors showed marked activity in the spleen focus assay. The
extracts yielded about 103 SFFU/ml in both Fv-1'° (DBA/2 and Ha/1CR) or Fv-1'
(BALB/c) hosts, indicating the presence of NB-tropic FV (Table III, A1). This
TABLE III
Occurrence of Friend Virus in Tumors, Culture Fluids, and Hosts of HFL/d Cells
* Supernate of 10% tissue homogenate in PBS.
$ Culture fluid supernate.
finding is consistent with the fact that the tumor was originally induced by
N,NB-tropic FV.
When these tumor cells were grown in culture (HFL/d-tc), FV detectable by
the spleen focus assay in vivo was revealed in supernatant fluids . Virus persisted
for at least 13 weekly passages, showing titers in the range of 10z-103 SFFU/ml
culture supernate 6 days after subculture. At the 16th and subsequent passages
FV could no longer be detected in supernates by the spleen focus assay. These
supernates were also virus negative when assayed in vitro by the XC method
Tissues tested
Source Preparation
Fu-1 type
of test cells
or mice
Virus
XC cell assay
PFU/ml
titer
Spleen focus
assay
SFFU/ml
A
1. HFL/d-sc tumor Ext* n 13.6x 10' 0.9x10'
b 3.8 x 10' 1.1 x 10'
2. HFL/d-tc cell culture SUP* n 0 0
b 0 0
B
1. HFL/d-tc tumor (grown s.c. in host Ext b 8 x 10'
infected with NB-tropic MoILV)
2. HFL/d-tc cells (cocultivated with Sup b 2 x 10'
NB-tropic LLV-F-infected embryo
cells)
3. HFL/d-tc cells (cocultivated with Sup b 1 x 10'
NB-tropic MoILV-infected embryo
cells)
C
1. Spleen of BALB/c host of HFL/d- Ext n 1.6x10' 7x10'
asl cells (passage no. 4 in vivo) b 6.9x10' 4x10'
2. Spleen of BALB/c host of HFL/d- Ext n 2.0x10' 1.1x10'
as2 cells (passage no. 3 in vivo) b 2.9x 10' 1.3x 10"
3. HFL/d-as2 cells returned to culture Sup b 0
(passage no . 2 in vitro)
4. HFL/d-as2 cells returned to culture Sup n 0
(passage no. 13 in vitro) b 0HERBERT A. FREEDMAN AND FRANK LILLY
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(Table III, A2) and showed no helper activity in vivo for the helper-dependent
SFFV (6).
The cell line, HFL/d-tc-11, derived from the HFL/d-sc tumor at a later date,
was indistinguishable from HFL/d-tc . When assayed in homologous hosts by the
spleen focus method, primary cultures ofthis cell line showed 1 x 103 SFFV/ml
supernatant fluid, and secondary cultures, 7 x 102 SFFV/ml. By the third
passage, however, virus could no longer be detected by the spleen focus assay. No
XC-active virus was detected in subsequent culture supernates assayed on either
Fv-1'° or Fv-1° embryos fibroblasts.
FV Production by HFL/b Cells.
￿
Supernatant fluids harvested from HFL/b-tc
cultures at the sixth passage generation showed NB-tropic FV at a concentration
of 4.3 x 102 SFFV/ml when assayed in vivo. When assayed in vitro by the XC
methodthis same preparation showed NB-tropic virus at a concentration of2.0 x
103 PFU/ml (Table IV). In subsequent passage generations, culture fluids which
have been tested for virus either in vitro or in vivo have invariably shown the
presence of virus at approximately these same levels. In contrast with "nonpro-
ducer" HFL/d-tc cells, HFL/b-tc cells produce complete FV, i.e., defective
SFFV plus helper virus.
Recovery of Friend Virus From HFL/d Cells.
￿
Although HFL/d-tc cells do not
produce infectiousFV in amounts detectable in either the spleen focus or the XC
assays, the cells might nevertheless still possess the genomes of either defective
SFFV or helper virus or both in unexpressed form . In an attempt to recover the
SFFV component of FV in infectious form, HFL/d-tc cells harvested from the
22nd passage were inoculated subcutaneously in BALB/c hosts which have been
infected 5.5 mo earlier with NB-tropic MoILV. By day 15 all recipients showed
palpable tumors, 0.5-1.0 cm in diameter. An extract of these tumors (supernate
of 10% PBS homogenate) assayed in vivo by the spleen focus method showed 8 x
103 SFFV/ml (Table 111, B1) . Since Mo1LV itself shows no activity in the spleen
focus assay, it appears that SFFV was rescued from HFL/d-tc cells during their
residence in helper virus-infected hosts.
Attempts to recover FV in vitro were made as well. Syngeneic embryo
fibroblasts infected in culture with NB-tropic Mo1LV were grown as monolayers
and allowed to reach approximately80% confluence . At this point HFL/d-tc cells
taken from the 34th passage were added to these fibroblast cultures. After
cocultivation for 7 days, supernates were removed and tested for spleen
focus-forming activity. These tests showed NB-tropic virus at a concentration of
approximately 24 SFFV/ml, confirming in vitro the rescue of SFFV by helper
virus (MoILV) already demonstrated in vivo.
Observations during the course of cocultivation suggested that a number of
HFL/d-tc cells adhered to areas of the fibroblast monolayers. These adherent
cells were not dislodged by vigorous agitation. With this in mind, cocultivation
was repeated using either NB-tropic Mo1LV or NB-tropic LLV-F-infected
syngeneic fibroblasts. All fibroblasts were infected in vitro. This time, however,
during the course of cocultivation with HFL/d-tc cells harvested from the 40th
passage generation, supernatant fluids were decanted daily, and replaced with
fresh growth media. Although this procedure resulted in the loss of many
nonadherent cells, supernatant fluids tested 7 days after the initiation of218
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TABLE IV
Occurrence of Friend Virus in Culture Supernates from Serially Transferred HFL/b-tc
Cells
* III 6A cells (3T3 cell line derived from a wild mouse by Dr. W. P. Rowe and donated to us by Dr. T.
Pincus, Sloan-Kettering Institute for Cancer Research, New York; these cells do not show an appar-
entFu-1 type, butrather they are equally efficient hosts for both N- andB-tropic viruses).
cocultivation with MoILV-infected fibroblasts showed 100 SFFU/ml. Superna-
tant fluids harvested from parallel cultures of HFL/d-tc cells with LLV-F-
infected fibroblasts contained 200 SFFU/ml (Table III, B2 and B3). Supernates
from parallel control cultures of HFL/d-tc cells with normal, uninfected
fibroblasts contained no spleen focus-forming activity.
Passage no .
Fu-1 type
of test cells
or mice
XC cell assay
PFUlml x 101
Spleen focus assay
SFFUlml x 102
4 b >2.0
5 b >2 .0
6 n 24 5.8
b 15 2.7
14 b >2 .0
20 b >2 .0
22 n 2.8
b 3.2
25 b 4.8
28 b 9.6
38 b >2.0
61 b >2.0
95 b >2.0
97 b 3.0
98 b >2.0
102 b >2.0
111 n, b* >2.0
118 n 1 .5
b 4.0
121 b 28HERBERT A. FREEDMAN AND FRANK LILLY
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Another method of recovering infectious FV from HFL/d-tc cells was encoun-
tered during the course of these experiments. As noted previously, inoculation of
these cells intraperitoneally into syngeneic hosts results in the growth of the cells
as an ascitic tumor in aportion of the recipients. A line of tumor serially passaged
in this ascites form, HFL/d-asl, was initiated with an intraperitoneal inoculum
of 2.5 x 105 HFL/d-tc cells from the 21st passage in culture. Subsequent passages
in vivo of the HFL/d-asl line were performed with whole ascites fluid which
contained cells morphologically indistinguishable from the original HFL/d-tc cell
line. Hosts harboring the fourth passage generation of these cells (71 days after
initiation of the ascites line) unexpectedly showed marked splenomegaly. When a
10% extract in PBS of one of these enlarged spleens was assayed in vivo forFV by
the spleen focus assay, a titer of 5.5 x 105 SFFU/ml was demonstrated. Assay of
the same preparations in vitro by the XC method revealed 4.3 x 106 PFU/ml.
This virus was NB-tropic (Table III, C1).
In order to confirm this phenomenon, 1 x 105 HFL/d-tc cells of the 33rd
passage were transplanted intraperitoneally to syngeneic hosts. Serial passage in
vivo resulted in the establishment of the ascitic HFL/d-as2 cell line. This time
hosts harboring the third serial passage generation (57 days after initiating of the
cell line) displayed splenomegaly. Extracts of these spleens showed NB-tropic FV
at a concentration of 1.2 x 10 6 SFFU/ml when assayed in vivo and NB-tropic
virus at a concentration of 2.5 x 106 PFU/ml when assayed by the XC method
(Table III, C2).
It should be emphasized that, although mice carrying HFL/d-as cells demon-
strate FV in their spleens, the HFL/d-as cells recovered from the peritoneal
cavity did not appear to be actively producing virus. When HFL/d-as cells,
harvested from the peritoneal cavity of viremic hosts, were carefully washed
before inoculation into the peritoneal cavity of normal syngeneic hosts, no
splenomegaly was observed until the third serial intraperitoneal passage.
Similarly, HFL/d-as2 cells maintained in vivo for six passage generations and
then returned to culture showed no virus activity when supernatant fluids were
assayed in vivo or in vitro (Table III, C3 and C4) . When after a total of six serial
passages in vitro, these cells were returned to the peritoneal cavity of syngeneic
hosts and passed serially, host splenomegaly did not reappear until approxi-
mately 87 days after reinitiation of intraperitoneal passage (fifth passage
generation).
Discussion
We have established cell lines in culture from tumors derived from the
enlarged spleens of FV-infected BALB/c (H-2d) and congenic BALB .B mice.
Morphologically these cell lines, as well as the tumors from which they were
derived, resemble those produced with similar techniques in other laboratories
(9-16) . Cultures of these cells are composed of red cell precursors in various
stages of differentiation. This description is consistent with the observation that
treatment of these cultures with dimethylsulfoxide results in an increase in both
the number of benzidine-positive cells and the total amount of detectable
hemoglobin (reference 17, and M. Adesnick, unpublished observation) . Thus, the
hematopoietic potential of these cultures has been established. The malignancy220
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potential of these cells was demonstrated by the formation and progressive
growth in situ of solid tumors after inoculation into syngeneic hosts.
When BALB/c tumors (HFL/d-sc) and their cultured counterparts (HFL/d-tc)
were assayed for production of FV, only solid tumor extracts and supernates from
early passages in culture gave positive results. Subsequent passages in vitro
revealed no infectious virus by either XC or spleen focus assays . In contrast,
supernates of cultures derived from BALB.B tumors persistently exhibited
infectious virus detectable in both XC and spleen focus assays. The nonproducer
status of HFL/d-tc cells corroborates and expands upon the results of Fieldsteel
et al. (15, 18, 19), who have also found that tumor cells,derived from FV-infected
BALB/c mice fail to produce virus in vitro.
In addition to infectivity assays, demonstration of virus-like particles with a
density of 1.16 g/cm 3 and virus-associated reverse transcriptase activity con-
firmed the presence of virus in HFL/b-tc culture supernates of the 28th, 38th, and
subsequent passage generations. Neither virus-like particles nor reverse tran-
scriptase activity were found in HFL/d-tc cultures (M. Adesnick, unpublished
observations) . No intra- or extracellular virus-like particles could be seen
electron microscopically in thin sections of HFL/d-tc cells. In contrast similar
preparations of HFL/b-tc cells showed C-type particles, both extracellularly and
budding from the cell surface (S . Panem, unpublished observation) .
The cell lines that we have established differ genotypically from each other
only with respect to the H-2 region of chromosome 17 (linkage group IX).
Nonproducer HFL/d-tc cells originated from a BALB/c mouse and possess the
H-2d haplotype; producer HFL/b-tc cells are of congenic BALB.B origin and
possess the H-2° haplotype derived from C57BL/10 mice . It is tempting to
speculate that this genotypic difference is the basis for the marked difference in
virus production noted between the two cell lines, but at this time it remains
possible that other factors are involved in these observations. Further studies will
be required to elucidate this point.
FV is a complex consisting of a spleen focus-forming component (SFFV) and
an associated helper (5, 19, 20). It is the SFFV which confers upon the virus
complex the ability to induce spleen foci and erythroleukemia. The presence of
the SFFV genome within nonproducer HFL/d-tc cells was demonstrated by
successful recovery of complete FV when these cellswere grown in thepresence of
either LLV-F- or MOILV-infected cells which can act as helpers. Recovery of FV
was successful both in vivo and in culture. This was accomplished in vivo by
subcutaneous transplantation of HFL/d-tc cells to syngeneic animals previously
infected with MOILV. Recovery in vitro was afforded by cocultivation of
HFL/d-tc cells with syngeneic embryo fibroblasts infected in vitro with LLV-F or
MOILV. Using analogous techniques both in vivo and in vitro, Fieldsteel et al .
(21) have also shown that their FV-transformed, nonproducer BALB/c cell line
contains the SFFV genome.
SFFV appears to be defective in that it cannot actively proliferate in the
absence of its associated helper virus. Thus it was conceivable that the
nonproducer status of HFL/d-tc cells was due to the loss of the helper virus
genome from these cells. However, this does not appear to be the case. The
presence of the helper virus genome within HFL/d-tc cells was suggested by theHERBERT A. FREEDMAN AND FRANK LILLY
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recoveryofcomplete FV from the spleens ofsyngeneic hosts in which HFL/d cells
(HFL/d-as) were passaged intraperitoneally. High titers of FV were demonstra-
ble in the spleens of hosts harboring HFL/d-as cells at the third and subsequent
serial intraperitoneal passages. In this context it is critical to note that the FV
recovered was NB tropic, as was the original virus used to induce the HFL/d cell
line. Since no exogenous helper virus was added, and since endogenous NB-tropic
viruses are not known to occur in nature, it appears that the helper virus genome
was indeed contained within nonproducer HFL/d-tc cells.
It should be emphasized, however, that although mice harboring HFL/d-as
cells demonstrate FV in their spleens, the HFL/d-as cells themselves did not
appear to be actively producing FV. This was evidenced by the fact that
HFL/d-as cells did not produce FV in culture, nor did washed HFL/d-as cells
induce splenomegaly upon intraperitoneal inoculation into normal syngeneic
hosts until several serial passages in vivo had been carried out.
These observations indicate that most HFL/d cells were not converted to
active FV producers by serial passage in the ascitic form. Rather, it appears that
an extremely small percentage of HFL/d cells have been converted to FV
producers or are continuously producing FV in quantities too small to detect by
infectivity assays. This small amount of virus could then be amplified by
replication in susceptible host cells. Another possibility is that a small number of
nonproducer HFL/d cells passaged intraperitoneally find their way to the host
spleen where their viral genomes are passed to new red cell precursors,
establishing a primary infection.
In all cases in which FV was recovered fromnonproducerHFL/d-tc cells, either
host cells or mouse embryo fibroblasts were present. Thus, the possibility exists
that HFL/d-tc cells cannot synthesize FV by themselves but car) do so only in
cooperation with a "helper cell." Lala has found that Ehrlich ascites cells
occasionally fuse with host cells in the peritoneal cavity (22). It is possible that
intraperitoneally passaged HFL/d-tc cells fuse with host cells in situ. Fusion of
HFL/d cells with host cells could perhaps result in expression of the viral
genomes in the form of infectious particles.
In these studies we have employed both the spleen focus and XC assays. The
spleen focus assaywas used because it is specific for complete FV, i.e., spleen foci
are induced by SFFV only in the presence ofhelper virus. The XC assay, on the
other hand, is capable of measuring helper virus even in the absence of SFFV.
Since the results obtained by both methods were comparable, both components
of FV were expressed coordinately .
Curiously, we were unable to establish the BALB.B tumor (HFL/b-sc) in
normal BALB.B hosts. Fragments ofFV-infected BALB.B spleens failed to grow
progressively upon transplantation to normal BALB.B mice. However, when
BALB.B recipients were rendered anemic by bleeding during the course oftumor
derivation, the BALB.B tumor was readily established. Transplants of BALB.B
tumors (HFL/b-sc) or their cultured counterparts (HFL/b-tc) consistently
regressed except in anemic hosts.
Although the mechanism of this effect of bleeding on tumor growth in BALB.B
hosts is as yet undetermined, two possible explanations can be postulated. One
explanation might be that the anemia induced by bleeding results in increased222
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levels of circulating erythropoietin which in turn stimulates the growth of
transplanted FV-transformed red cell precursors . This possibility would agree
with earlier studies indicating that erythropoietin increases susceptibility to FV
by increasing the number or the susceptibility of target cells (i .e ., erythropoietin-
sensitive primitive erythroid cells) before transformation (23) . Another possible
explanation is that bleeding not only decreases humoral antibody levels but also
removes migrating immunocytes which reject the tumor cells . In fact, both
mechanism may be operating in concert.
Summary
Cell lines have been established in culture from Friend virus-induced tumors of
BALB/c (H-2d) and congenic BALB/c-H-2° (BALB .B) origin. Spleens from
virus-infected hosts in the terminal stages of erythroleukemic disease provided
tissues for the establishment of subcutaneously transplantable tumors of both
strains . Subsequently cells of these tumors were introduced into culture and
passed serially. Complete, infectious Friend virus (FV) has been routinely
recovered from culture supernates of BALB.B tumor cells (HFL/b) throughout
its 2-yr passage history. However, after only a few transfer generations in culture
BALB/c tumor cells (HFL/d) became nonproducers of virus detectable in either
the spleen focus assay in vivo or the XC assay in vitro. Nonproducer HFL/d cells
possessed the complete genomes of the components of the FV complex, since FV
could be recovered from them either by cocultivation with helper virus-infected
syngeneic embryo fibroblasts or by serial passage in the ascitic form in normal,
syngeneic adult hosts.
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